Non-fibrillar collagens: Key mediators of post-infarction cardiac remodeling?

Journal of Molecular and Cellular Cardiology

Volumn 48, Issue 3, 2010, Pages 530-537

  Shamhart, Patricia E ^a   Meszaros, J Gary ^a  

^a Northeastern Ohio Medical University   (United States)

Author keywords

Integrins; Matrix metalloproteinases; Myocardial infarction; Myofibroblasts; Serine proteases; Wound healing

Indexed keywords

COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; COLLAGEN TYPE 5; COLLAGEN TYPE 6; MATRIX METALLOPROTEINASE; SERINE PROTEINASE;

CELL DIFFERENTIATION; COLLAGEN DEGRADATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FIBRIN FORMATION; GENE MUTATION; HEART INFARCTION; HEART MUSCLE FIBROSIS; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; WOUND HEALING;

ANIMALS; HUMANS; MATRIX METALLOPROTEINASES; MODELS, BIOLOGICAL; MYOCARDIAL INFARCTION; MYOCARDIUM; NON-FIBRILLAR COLLAGENS; WOUND HEALING;

EID: 77649275832     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2009.06.017     Document Type: Review

References (62)

1. Weber K.T. Cardiac interstitium in health and disease: the fibrillar collagen network. J. Am. Coll. Cardiol. 1989 Jun, 13(7):1637-1652.
2. Weis S.M., Emery J.L., Becker K.D., McBride D.J., Omens J.H., McCulloch A.D. Myocardial mechanics and collagen structure in the osteogenesis imperfecta murine (oim). Circ. Res. 2000 Oct 13, 87(8):663-669.
3. Baudino T.A., Carver W., Giles W., Borg T.K. Cardiac fibroblasts: friend or foe?. Am. J. Physiol, Heart Circ. Physiol. 2006 Sep, 291(3):H1015-H1026.
4. Naugle J.E., Olson E.R., Zhang X., Mase S.E., Pilati C.F., Maron M.B., et al. Type VI collagen induces cardiac myofibroblast differentiation: implications for postinfarction remodeling. Am. J. Physiol, Heart Circ. Physiol. 2006 Jan, 290(1):H323-H330.
5. Elliott J.T., Woodward J.T., Langenbach K.J., Tona A., Jones P.L., Plant A.L. Vascular smooth muscle cell response on thin films of collagen. Matrix Biol. 2005 Oct, 24(7):489-502.
6. Wei S., Chow L.T., Shum I.O., Qin L., Sanderson J.E. Left and right ventricular collagen type I/III ratios and remodeling post-myocardial infarction. J. Card. Fail. 1999 Jun, 5(2):117-126.
7. Adachi E., Hayashi T. In vitro formation of hybrid fibrils of type V collagen and type I collagen. Limited growth of type I collagen into thick fibrils by type V collagen. Connect. Tissue Res. 1986, 14(4):257-266.
8. Wenstrup R.J., Florer J.B., Brunskill E.W., Bell S.M., Chervoneva I., Birk D.E. Type V collagen controls the initiation of collagen fibril assembly. J. Biol. Chem. 2004 Dec 17, 279(51):53331-53337.
9. Schwarze U., Atkinson M., Hoffman G.G., Greenspan D.S., Byers P.H. Null alleles of the COL5A1 gene of type V collagen are a cause of the classical forms of Ehlers-Danlos syndrome (types I and II). Am. J. Hum. Genet. 2000 Jun, 66(6):1757-1765.
10. Wenstrup R.J., Florer J.B., Davidson J.M., Phillips C.L., Pfeiffer B.J., Menezes D.W., et al. Murine model of the Ehlers-Danlos syndrome. col5a1 haploinsufficiency disrupts collagen fibril assembly at multiple stages. J. Biol. Chem. 2006 May 5, 281(18):12888-12895.
11. Hammer D., Leier C.V., Baba N., Vasko J.S., Wooley C.F., Pinnell S.R. Altered collagen composition in a prolapsing mitral valve with ruptured chordae tendineae. Am. J. Med. 1979 Nov, 67(5):863-866.
12. Bashey R.I., Donnelly M., Insinga F., Jimenez S.A. Growth properties and biochemical characterization of collagens synthesized by adult rat heart fibroblasts in culture. J. Mol. Cell. Cardiol. 1992 Jul, 24(7):691-700.
13. Lawrence R., Hartmann D.J. Sonenshein GE. Transforming growth factor beta 1 stimulates type V collagen expression in bovine vascular smooth muscle cells. J. Biol. Chem. 1994 Apr 1, 269(13):9603-9609.
14. Sakata N., Jimi S., Takebayashi S., Marques M.A. Type V collagen represses the attachment, spread, and growth of porcine vascular smooth muscle cells in vitro. Exp. Mol. Pathol. 1992 Feb, 56(1):20-36.
15. Fukuda K., Koshihara Y., Oda H., Ohyama M., Ooyama T. Type V collagen selectively inhibits human endothelial cell proliferation. Biochem. Biophys. Res. Commun. 1988 Mar 30, 151(3):1060-1068.
16. Honda M., Goto Y., Kuzuo H., Ishikawa S., Morioka S., Yamori Y., et al. Biochemical remodeling of collagens in the heart of spontaneously hypertensive rats. Jpn. Circ. J. 1993, 57:434-441.
17. Ooshima A. Collagen alpha B chain: increased proportion in human atherosclerosis. Science 1981 Aug 7, 213(4508):666-668.
18. Yoshikane H., Honda M., Goto Y., Morioka S., Ooshima A., Moriyama K. Collagen in dilated cardiomyopathy-scanning electron microscopic and immunohistochemical observations. Jpn. Circ. J. 1992 Sep, 56(9):899-910.
19. Narayanan A.S., Page R.C. Synthesis of type V collagen by fibroblasts derived from normal, inflamed and hyperplastic human connective tissues. Coll. Relat. Res. 1985 Sep, 5(4):297-304.
20. Lincoln J., Florer J.B., Deutsch G.H., Wenstrup R.J., Yutzey K.E. ColVa1 and ColXIa1 are required for myocardial morphogenesis and heart valve development. Dev. Dyn. 2006 Dec, 235(12):3295-3305.
21. Yurchenco P.D., Schittny J.C. Molecular architecture of basement membranes. FASEB J. 1990 Apr 1, 4(6):1577-1590.
22. LeBleu V.S., Macdonald B., Kalluri R. Structure and function of basement membranes. Exp. Biol. Med. (Maywood). 2007 Oct, 232(9):1121-1129.
23. Khoshnoodi J., Pedchenko V., Hudson B.G. Mammalian collagen IV. Microsc. Res. Tech. 2008 May, 71(5):357-370.
24. Kuo H.J., Maslen C.L., Keene D.R., Glanville R.W. Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen. J. Biol. Chem. 1997 Oct 17, 272(42):26522-26529.
25. Bonaldo P., Russo V., Bucciotti F., Doliana R., Colombatti A. Structural and functional features of the alpha 3 chain indicate a bridging role for chicken collagen VI in connective tissues. Biochemistry 1990 Feb 6, 29(5):1245-1254.
26. Jongewaard I.N., Lauer R.M., Behrendt D.A., Patil S., Klewer S.E. Beta 1 integrin activation mediates adhesive differences between trisomy 21 and non-trisomic fibroblasts on type VI collagen. Am. J. Med. Genet. 2002 May 15, 109(4):298-305.
27. Tulla M., Pentikainen O.T., Viitasalo T., Kapyla J., Impola U., Nykvist P., et al. Selective binding of collagen subtypes by integrin alpha 1I, alpha 2I, and alpha 10I domains. J. Biol. Chem. 2001 Dec 21, 276(51):48206-48212.
28. Bryant J.E., Shamhart P.E., Luther D.J., Olson E.R., Koshy J.C., Costic D.J., et al. Cardiac myofibroblast differentiation is attenuated by alpha(3) integrin blockade: potential role in post-MI remodeling. J. Mol. Cell. Cardiol. 2009 Feb, 46(2):186-192.
29. Eghbali M., Blumenfeld O., Seifter S. Localization of the fibers I, III, and IV collagen mRNAS in rat heart cells by in situ hybridization. J. Mol. Cell. Cardiol. 1989, 21:103-113.
30. Orr A.W., Lee M.Y., Lemmon J.A., Yurdagul A., Gomez M.F., Bortz P.D., et al. Molecular mechanisms of collagen isotype-specific modulation of smooth muscle cell phenotype. Arterioscler. Thromb. Vasc. Biol. 2009 Feb, 29(2):225-231.
31. Sone M., Itoh H., Yamashita J., Yurugi-Kobayashi T., Suzuki Y., Kondo Y., et al. Different differentiation kinetics of vascular progenitor cells in primate and mouse embryonic stem cells. Circulation 2003 Apr 29, 107(16):2085-2088.
32. Xiao Q., Zeng L., Zhang Z., Hu Y., Xu Q. Stem cell-derived Sca-1+ progenitors differentiate into smooth muscle cells, which is mediated by collagen IV-integrin alpha1/beta1/alphav and PDGF receptor pathways. Am. J. Physiol., Cell Physiol. 2007 Jan, 292(1):C342-C352.
33. Schenke-Layland K., Rhodes K.E., Angelis E., Butylkova Y., Heydarkhan-Hagvall S., Gekas C., et al. Reprogrammed mouse fibroblasts differentiate into cells of the cardiovascular and hematopoietic lineages. Stem Cells 2008 Jun, 26(6):1537-1546.
34. Macfelda K., Kapeller B., Wilbacher I., Losert U.M. Behavior of cardiomyocytes and skeletal muscle cells on different extracellular matrix components-relevance for cardiac tissue engineering. Artif. Organs 2007 Jan, 31(1):4-12.
35. Yamanishi A., Kusachi S., Nakahama M., Ninomiya Y., Watanabe T., Kumashiro H., et al. Sequential changes in the localization of the type IV collagen alpha chain in the infarct zone: immunohistochemical study of experimental myocardial infarction in the rat. Pathol. Res. Pract. 1998, 194(6):413-422.
36. Watanabe T., Kusachi S., Yamanishi A., Kumashiro H., Nunoyama H., Sano I., et al. Localization of type IV collagen alpha chain in the myocardium of dilated and hypertrophic cardiomyopathy. Jpn. Heart J. 1998 Nov, 39(6):753-762.
37. Aragno M., Mastrocola R., Alloatti G., Vercellinatto I., Bardini P., Geuna S., et al. Oxidative stress triggers cardiac fibrosis in the heart of diabetic rats. Endocrinology 2008 Jan, 149(1):380-388.
38. Duff K., Williamson R., Richards S. Expression of genes encoding 2 chains of the collagen type-VI molecule during human fetal heart development. Int. J. Cardiol. 1990, 27:128-129.
39. Timple R., Engel J. Type VI collagen. Structure and function of collagen types 1987, 105-143. Academic Press, New York. R. Mayne, R.E. Burgeson (Eds.).
40. Amento E., Ehsani N., Palmer H., Libby P. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler. Thromb. 1991, 11:1223-1230.
41. Colombatti A., Bonaldo P., Ainger K., Bressan G.M., Volpin D. Biosynthesis of chick type VI collagen. I. Intracellular assembly and molecular structure. J. Biol. Chem. 1987 Oct 25, 262(30):14454-14460.
42. Fitzgerald J., Rich C., Zhou F.H., Hansen U. Three novel collagen VI chains, alpha4(VI), alpha5(VI), and alpha6(VI). J. Biol. Chem. 2008 Jul 18, 283(29):20170-20180.
43. Engvall E., Hessle H., Klier G. Molecular assembly, secretion, and matrix deposition of type VI collagen. J. Cell Biol. 1986 Mar, 102(3):703-710.
44. Lampe A.K., Bushby K.M. Collagen VI related muscle disorders. J. Med. Genet. 2005 Sep, 42(9):673-685.
45. Bonaldo P., Braghetta P., Zanetti M., Piccolo S., Volpin D., Bressan G.M. Collagen VI deficiency induces early onset myopathy in the mouse: an animal model for Bethlem myopathy. Hum. Mol. Genet. 1998 Dec, 7(13):2135-2140.
46. Irwin W.A., Bergamin N., Sabatelli P., Reggiani C., Megighian A., Merlini L., et al. Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency. Nat. Genet. 2003 Dec, 35(4):367-371.
47. Sabatelli P., Bonaldo P., Lattanzi G., Braghetta P., Bergamin N., Capanni C., et al. Collagen VI deficiency affects the organization of fibronectin in the extracellular matrix of cultured fibroblasts. Matrix Biol. 2001 Nov, 20(7):475-486.
48. Davies G.E., Howard C.M., Gorman L.M., Farrer M.J., Holland A.J., Williamson R., et al. Polymorphisms and linkage disequilibrium in the COL6A1 and COL6A2 gene cluster: novel DNA polymorphisms in the region of a candidate gene for congenital heart defects in Down's syndrome. Hum. Genet. 1993 Jan, 90(5):521-525.
49. Klewer S.E., Krob S.L., Kolker S.J., Kitten G.T. Expression of type VI collagen in the developing mouse heart. Dev. Dyn. 1998 Mar, 211(3):248-255.
50. Gittenberger-de Groot A.C., Bartram U., Oosthoek P.W., Bartelings M.M., Hogers B., Poelmann R.E., et al. Collagen type VI expression during cardiac development and in human fetuses with trisomy 21. Anat. Rec. A Discov. Mol. Cell Evol. Biol. 2003 Dec, 275(2):1109-1116.
51. Shimizu M., Umeda K., Sugihara N., Yoshio H., Ino H., Takeda R., et al. Collagen remodelling in myocardia of patients with diabetes. J. Clin. Pathol. 1993 Jan, 46(1):32-36.
52. Polyakova V., Miyagawa S., Szalay Z., Risteli J., Kostin S. Atrial extracellular matrix remodelling in patients with atrial fibrillation. J. Cell. Mol. Med. 2008 Jan-Feb, 12(1):189-208.
53. Spiro M., Crowley T. Increased rat myocardial type VI collagen in diabetes mellitus and hypertension. Diabetolgia 1993, 36:93-98.
54. Lindsey M.L. Novel strategies to delineate matrix metalloproteinase (MMP)-substrate relationships and identify targets to block MMP activity. Mini Rev. Med. Chem. 2006 Nov, 6(11):1243-1248.
55. Tyagi S.C. Proteinases and myocardial extracellular matrix turnover. Mol. Cell. Biochem. 1997 Mar, 168(1-2):1-12.
56. Xu X., Chen Z., Wang Y., Yamada Y., Steffensen B. Functional basis for the overlap in ligand interactions and substrate specificities of matrix metalloproteinases-9 and -2. Biochem. J. 2005 Nov 15, 392(Pt 1):127-134.
57. Kielty C.M., Lees M., Shuttleworth C.A., Woolley D. Catabolism of intact type VI collagen microfibrils: susceptibility to degradation by serine proteinases. Biochem. Biophys. Res. Commun. 1993 Mar 31, 191(3):1230-1236.
58. Wu Q., Kuo H.C., Deng G.G. Serine proteases and cardiac function. Biochim. Biophys. Acta 2005 Aug 1, 1751(1):82-94.
59. Hinz B., Phan S.H., Thannickal V.J., Galli A., Bochaton-Piallat M.L., Gabbiani G. The myofibroblast: one function, multiple origins. Am. J. Pathol. 2007 Jun, 170(6):1807-1816.
60. Kuwahara F., Kai H., Tokuda K., Kai M., Takeshita A., Egashira K., et al. Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation 2002 Jul 2, 106(1):130-135.
61. Petrov V.V., Fagard R.H., Lijnen P.J. Stimulation of collagen production by transforming growth factor-beta1 during differentiation of cardiac fibroblasts to myofibroblasts. Hypertension 2002 Feb, 39(2):258-263.
62. Liu X., Sun S.Q., Hassid A., Ostrom R.S. cAMP inhibits transforming growth factor-beta-stimulated collagen synthesis via inhibition of extracellular signal-regulated kinase 1/2 and Smad signaling in cardiac fibroblasts. Mol. Pharmacol. 2006 Dec, 70(6):1992-2003.